Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2001 Jun;10(3):155–162. doi: 10.1080/09629350123956

The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers.

D Muhvić 1, V El-Samalouti 1, H D Flad 1, B Radosević-Stasić 1, D Rukavina 1
PMCID: PMC1781699  PMID: 11545252

Abstract

BACKGROUND: Cell-wall components of Gram-positive and Gram-negative bacteria induce the production of cytokines in human peripheral blood mononuclear cells. These cytokines are the main mediators of local or systemic inflammatory reaction that can contribute to the development of innate immunity. AIMS: This study was performed to analyze the involvement of CD14 molecule in the activation of human monocytes by peptidoglycan monomer (PGM) obtained by biosynthesis from culture fluid of penicillin-treated Brevibacterium divaricatum NRLL-2311. METHODS: Cytokine release of interleukin (IL)-1, IL-6 and tumor necrosis factor-alpha from human monocytes via soluble CD14 (sCD14) or membrane-associated (mCD14) receptor using anti-CD14 monoclonal antibody (MEM-18) or lipid A structure (compound 406) was measured in bioassays. RESULTS: The results demonstrated that PGM in the presence of human serum might induce the monokine release in a dose-dependent manner. The addition of sCD14 at physiologic concentrations enhanced the PGM-induced monokine release, while the monokine inducing capacity of PGM in the presence of sCD14 was inhibited by MEM-18. Effects of PGM were also blocked by glycolipid, compound 406, suggesting the involvement of binding structures similar to those for lipopolysaccharide. CONCLUSION: Activation of human monocytes by PGM involves both forms of CD14 molecule, sCD14 and mCD14.

Full Text

The Full Text of this article is available as a PDF (189.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awada A., van der Auwera P., Meunier F., Daneau D., Klastersky J. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis. 1992 Jul;15(1):33–48. doi: 10.1093/clinids/15.1.33. [DOI] [PubMed] [Google Scholar]
  2. Bowie A., O'Neill L. A. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol. 2000 Apr;67(4):508–514. doi: 10.1002/jlb.67.4.508. [DOI] [PubMed] [Google Scholar]
  3. Dziarski R., Jin Y. P., Gupta D. Differential activation of extracellular signal-regulated kinase (ERK) 1, ERK2, p38, and c-Jun NH2-terminal kinase mitogen-activated protein kinases by bacterial peptidoglycan. J Infect Dis. 1996 Oct;174(4):777–785. doi: 10.1093/infdis/174.4.777. [DOI] [PubMed] [Google Scholar]
  4. Dziarski R., Tapping R. I., Tobias P. S. Binding of bacterial peptidoglycan to CD14. J Biol Chem. 1998 Apr 10;273(15):8680–8690. doi: 10.1074/jbc.273.15.8680. [DOI] [PubMed] [Google Scholar]
  5. Dziarski R., Ulmer A. J., Gupta D. Interactions of CD14 with components of gram-positive bacteria. Chem Immunol. 2000;74:83–107. doi: 10.1159/000058761. [DOI] [PubMed] [Google Scholar]
  6. Dziarski R., Viriyakosol S., Kirkland T. N., Gupta D. Soluble CD14 enhances membrane CD14-mediated responses to peptidoglycan: structural requirements differ from those for responses to lipopolysaccharide. Infect Immun. 2000 Sep;68(9):5254–5260. doi: 10.1128/iai.68.9.5254-5260.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feist W., Ulmer A. J., Wang M. H., Musehold J., Schlüter C., Gerdes J., Herzbeck H., Brade H., Kusumoto S., Diamantstein T. Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A. FEMS Microbiol Immunol. 1992 Jan;4(2):73–89. doi: 10.1111/j.1574-6968.1992.tb04973.x. [DOI] [PubMed] [Google Scholar]
  8. Gabrilovac J., Tomasić J., Boranić M., Martin-Kleiner I., Osmak M. In vivo and in vitro modulation of NK and ADCC activities of mouse spleen cells by peptidoglycan monomer (PGM). Res Exp Med (Berl) 1989;189(4):265–273. doi: 10.1007/BF01852258. [DOI] [PubMed] [Google Scholar]
  9. Galanos C., Lüderitz O., Westphal O. Preparation and properties of a standardized lipopolysaccharide from salmonella abortus equi (Novo-Pyrexal). Zentralbl Bakteriol Orig A. 1979 Apr;243(2-3):226–244. [PubMed] [Google Scholar]
  10. Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
  11. Glauser M. P. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med. 2000 Sep;28(9 Suppl):S4–S8. doi: 10.1097/00003246-200009001-00002. [DOI] [PubMed] [Google Scholar]
  12. Gold M. R., Miller C. L., Mishell R. I. Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions. Infect Immun. 1985 Sep;49(3):731–741. doi: 10.1128/iai.49.3.731-741.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gupta D., Kirkland T. N., Viriyakosol S., Dziarski R. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem. 1996 Sep 20;271(38):23310–23316. doi: 10.1074/jbc.271.38.23310. [DOI] [PubMed] [Google Scholar]
  14. Heumann D., Glauser M. P., Calandra T. Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol. 1998 Feb;1(1):49–55. doi: 10.1016/s1369-5274(98)80142-2. [DOI] [PubMed] [Google Scholar]
  15. Holst O., Ulmer A. J., Brade H., Flad H. D., Rietschel E. T. Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol. 1996 Dec 1;16(2):83–104. doi: 10.1111/j.1574-695X.1996.tb00126.x. [DOI] [PubMed] [Google Scholar]
  16. Keglević D., Ladesić B., Tomasić J., Valinger Z., Naumski R. Isolation procedure and properties of monomer unit from lysozyme digest of peptidoglycan complex excreted into the medium by penicillin-treated Brevibacterium divaricatum mutant. Biochim Biophys Acta. 1979 Jun 12;585(2):273–281. doi: 10.1016/0304-4165(79)90027-8. [DOI] [PubMed] [Google Scholar]
  17. Lien E., Means T. K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M. J., Oikawa M., Qureshi N., Monks B. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest. 2000 Feb;105(4):497–504. doi: 10.1172/JCI8541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Loppnow H., Flad H. D., Dürrbaum I., Musehold J., Fetting R., Ulmer A. J., Herzbeck H., Brandt E. Detection of interleukin 1 with human dermal fibroblasts. Immunobiology. 1989 Jun;179(2-3):283–291. doi: 10.1016/S0171-2985(89)80023-3. [DOI] [PubMed] [Google Scholar]
  19. Majcherczyk P. A., Langen H., Heumann D., Fountoulakis M., Glauser M. P., Moreillon P. Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity. J Biol Chem. 1999 Apr 30;274(18):12537–12543. doi: 10.1074/jbc.274.18.12537. [DOI] [PubMed] [Google Scholar]
  20. Means T. K., Golenbock D. T., Fenton M. J. The biology of Toll-like receptors. Cytokine Growth Factor Rev. 2000 Sep;11(3):219–232. doi: 10.1016/s1359-6101(00)00006-x. [DOI] [PubMed] [Google Scholar]
  21. Pugin J., Heumann I. D., Tomasz A., Kravchenko V. V., Akamatsu Y., Nishijima M., Glauser M. P., Tobias P. S., Ulevitch R. J. CD14 is a pattern recognition receptor. Immunity. 1994 Sep;1(6):509–516. doi: 10.1016/1074-7613(94)90093-0. [DOI] [PubMed] [Google Scholar]
  22. Radoŝević-Staŝić B., Trobonjaĉa Z., Petković M., Milin C., Cuk M., Muhvić D., Ravlić-Gulan J., Marić I., Rukavina D. Immunoregulating effects of peptidoglycan monomer linked with zinc in adult mice. Int Arch Allergy Immunol. 1995 Mar;106(3):219–228. doi: 10.1159/000236846. [DOI] [PubMed] [Google Scholar]
  23. Ravlić-Gulan J., Radosević-Stasić B., Trobonjaca Z., Petković M., Cuk M., Rukavina D. On the role of T lymphocytes in stimulation of humoral immunity induced by peptidoglycan-monomer linked with zinc. Int Arch Allergy Immunol. 1999 May;119(1):13–22. doi: 10.1159/000024170. [DOI] [PubMed] [Google Scholar]
  24. Rietschel E. T., Schletter J., Weidemann B., El-Samalouti V., Mattern T., Zähringer U., Seydel U., Brade H., Flad H. D., Kusumoto S. Lipopolysaccharide and peptidoglycan: CD14-dependent bacterial inducers of inflammation. Microb Drug Resist. 1998 Spring;4(1):37–44. doi: 10.1089/mdr.1998.4.37. [DOI] [PubMed] [Google Scholar]
  25. Schwandner R., Dziarski R., Wesche H., Rothe M., Kirschning C. J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem. 1999 Jun 18;274(25):17406–17409. doi: 10.1074/jbc.274.25.17406. [DOI] [PubMed] [Google Scholar]
  26. Sriskandan S., Cohen J. Gram-positive sepsis. Mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am. 1999 Jun;13(2):397–412. doi: 10.1016/s0891-5520(05)70082-9. [DOI] [PubMed] [Google Scholar]
  27. Stelter F., Pfister M., Bernheiden M., Jack R. S., Bufler P., Engelmann H., Schütt C. The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. Eur J Biochem. 1996 Mar 1;236(2):457–464. doi: 10.1111/j.1432-1033.1996.00457.x. [DOI] [PubMed] [Google Scholar]
  28. Tapping R. I., Tobias P. S. Soluble CD14-mediated cellular responses to lipopolysaccharide. Chem Immunol. 2000;74:108–121. doi: 10.1159/000058751. [DOI] [PubMed] [Google Scholar]
  29. Valinger Z., Ladesić B., Hrsak I., Tomasić J. Relationship of metabolism and immunostimulating activity of peptidoglycan monomer in mice after three different routes of administration. Int J Immunopharmacol. 1987;9(3):325–332. doi: 10.1016/0192-0561(87)90057-9. [DOI] [PubMed] [Google Scholar]
  30. Wang M. H., Flad H. D., Feist W., Brade H., Kusumoto S., Rietschel E. T., Ulmer A. J. Inhibition of endotoxin-induced interleukin-6 production by synthetic lipid A partial structures in human peripheral blood mononuclear cells. Infect Immun. 1991 Dec;59(12):4655–4664. doi: 10.1128/iai.59.12.4655-4664.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Weidemann B., Schletter J., Dziarski R., Kusumoto S., Stelter F., Rietschel E. T., Flad H. D., Ulmer A. J. Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun. 1997 Mar;65(3):858–864. doi: 10.1128/iai.65.3.858-864.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wright S. D. CD14 and innate recognition of bacteria. J Immunol. 1995 Jul 1;155(1):6–8. [PubMed] [Google Scholar]
  33. Yoshimura A., Lien E., Ingalls R. R., Tuomanen E., Dziarski R., Golenbock D. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999 Jul 1;163(1):1–5. [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES